> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Surrogate Endpoint Table
- URL: https://www.fdaweb.com/comments-sought-on-surrogate-endpoint-table/
- Published: 2018-10-30T12:00:00.000Z
- Updated: 2026-09-15T00:41:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142705

*Federal Register* notice: FDA has opened a public docket to receive suggestions and comments on the agency’s publication of its surrogate endpoint table (SE table). FDA has developed a [Web page](https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm613636.htm?ref=fdaweb.com) that displays the SE table, describes the purpose of the table, and provides additional background information. Comments received on the SE table will help FDA determine its utility and may assist it in developing future iterations of the SE table and identifying best methods for conveying information about SEs on the FDA’s Web site. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-10-30/pdf/2018-23641.pdf?ref=fdaweb.com).